RedHill's Opaganib Selected by the NIH Radiation and Nuclear Countermeasures Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| REDHILL BIO SP ADS (NASDAQ: RDHL) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $16.54 | |||
| Open | $0.41 | 52 Week Low | $8.10 | |||
| Day High | $0.45 | P/E | N/A | |||
| Day Low | $0.41 | EPS | $0.00 | |||
| Volume | 108,145 | |||||
